Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2972602 | The Journal of Heart and Lung Transplantation | 2008 | 5 Pages |
Abstract
The Levitronix device is effective in rescuing critically ill “moribund” patients and can provide an opportunity for low-cost support and optimization of their condition prior to deciding whether a more expensive device should be placed or if transplantation should be undertaken. Better candidate selection for further procedures can then be allowed.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Fabio MD, Paula RGN, Mohammed FRCS, PhD, Mario FRCS, PhD, John R. FRCS, Toufan FRCS, Gilles D. FRCS, Asghar FRCS, Emma J. MRCP, PhD,